2,452 findings · Mixed · published 2017+
- MixedGood
Roux-en-Y gastric bypass (RYGB) and Health Behavior Intervention (HBI) are cost-effective strategies for managing class III obesity, whereas current-price pharmacotherapies (semaglutide and tirzepatide) are not cost-effective compared to no treatment or HBI.
For individuals with class III obesity, Roux-en-Y gastric bypass offers the best long-term health outcomes and cost-effectiveness. Health Behavior Intervention (13 counseling sessions) is also cost-effective. Current GLP-1/GIP medications are not cost-effective at current prices, though lower prices could change this.
Qualifies 2025New - MixedGood
Combining CPAP with weight loss (via pharmacotherapy or lifestyle) yields greater improvements in cardiovascular risk profiles (specifically systolic blood pressure) than either treatment alone.
If you use CPAP for sleep apnea, adding weight loss (through diet, exercise, or medications like Tirzepatide) provides extra protection for your heart and blood pressure that CPAP alone does not offer. The combination is superior to either treatment by itself.
Supports 2025New - MixedGood
Low-load, high-volume resistance training is as effective as high-load resistance training for maximizing strength.
If your goal is to get stronger (maximal strength), you need to lift heavier loads. Lighter weights with high repetitions are not as effective for this specific goal.
Refutes 2025New - MixedGood
There is significant individual variability in response to all anti-obesity medications, with a substantial subset of patients experiencing weight gain or failing to achieve target weight loss, regardless of the drug class.
Not everyone responds to weight loss drugs the same way. Some people gain weight even on strong medications like tirzepatide. If you don't see results, it may be due to individual biological differences, not just effort. Discuss switching medications with your doctor.
Qualifies 2024 - MixedGood
When total training volume is equated, resistance training performed 3 times per week produces greater absolute strength gains than 4 times per week in young men.
If you are training 4 days a week and not seeing strength gains, check your volume. If you are already doing enough total work, switching to 3 days a week might actually help you get stronger, provided you keep the total sets and reps the same. Do not just add a 4th day on top of your current routine expecting better results; consolidate your volume into fewer sessions.
Qualifies 2020 - MixedGood
Training frequency does not significantly impact muscle hypertrophy (measured by circumference) when total training volume is equated.
If your goal is muscle size, focus on hitting your total weekly sets and reps, not how many days you train. Whether you train 3 or 4 days a week, as long as the total volume is the same, your muscle growth will be similar. Do not feel pressured to add extra days just for the sake of frequency.
Refutes 2020 - MixedGood
High HDD diets shift gut microbial community composition from fiber-degrading taxa (e.g., Prevotella) to mucin-degrading taxa (e.g., Bacteroides, Akkermansia) due to nutrient limitation.
If you eat a diet low in fiber and high in processed ingredients, your gut bacteria may shift to eat your gut lining (mucin) instead of your food. To encourage beneficial fiber-eating bacteria, increase your intake of whole plant foods.
Supports 2024 - MixedGood
Supplementation with marine long-chain n-3 polyunsaturated fatty acids (EPA and DHA) reduces cardiovascular risk in primary prevention and secondary prevention for patients with low baseline status and limited polypharmacy, but recent trials show null results in highly medicated secondary prevention populations.
Aim to eat fatty fish regularly to get EPA and DHA. If you are not eating fish, consider supplementation, especially if you have low baseline levels. However, if you are already on many heart medications, the added benefit of supplements may be minimal.
Qualifies 2017 - MixedGood
When resistance training is performed to volitional fatigue, muscle hypertrophy is independent of the external load used (high vs. low), provided volume load is matched or effort is equivalent.
You do not need to lift heavy weights to build muscle. If you use lighter weights (30-40% of your max), you must perform more reps (20-25) and push until you physically cannot complete another rep with good form. This effort-to-failure approach yields the same muscle growth as heavy lifting (70-80% max) done for fewer reps (8-12). Ensure you eat enough protein (at least 1.6g per kg of body weight) and train consistently 3 times a week.
Refutes 2025New - MixedGood
Using lean body mass (LBM) and body fat percentage (BF) in reference equations for peak oxygen uptake (VO2peak) provides better calibration for overweight and obese individuals compared to equations based on total body mass.
If you are overweight or obese, standard fitness tests that use your total body weight to predict your maximum oxygen uptake (VO2peak) likely overestimate your fitness level. To get an accurate assessment of your cardiorespiratory health, especially if you are older, use reference equations that account for your lean body mass and body fat percentage. This prevents being falsely categorized as 'fit' when your actual functional capacity may be lower.
Supports 2025New - MixedGood
Electronic health record (EHR) data from the one-year period prior to initiating anti-obesity medication (AOM) contains sufficient multidimensional clinical signals to identify distinct obesity subtypes (clusters) with unique physiological profiles, enabling precision medicine approaches that outperform traditional BMI-based classifications.
If you are considering obesity medication, ask your doctor about 'deep phenotyping.' This means using your full medical history (labs, vitals, diagnoses) from the past year to group you into a specific 'obesity subtype.' This helps predict which medication will work best for you, rather than just using your BMI. It reduces the guesswork in choosing between different drugs like GLP-1 agonists or others.
Supports 2025New - MixedGood
Bariatric surgery (specifically Roux-en-Y gastric bypass, sleeve gastrectomy, and biliopancreatic diversion) provides superior long-term weight loss (average 27% over 15 years) and quality of life improvements compared to lifestyle interventions and pharmacotherapy, despite carrying higher risks of postoperative complications.
If you have a BMI over 40 (or over 35 with health issues) and lifestyle changes haven't worked, bariatric surgery is the most effective medical intervention for long-term weight loss. It involves physically altering your stomach and intestines to restrict food intake and/or absorption. While it carries surgical risks and requires lifelong vitamin monitoring, it offers the highest chance of significant, sustained weight loss and improved quality of life compared to drugs or diet alone.
Supports 2024 - MixedGood
Combination therapies (e.g., Phentermine/Topiramate, Naltrexone/Bupropion) offer superior weight loss compared to monotherapy by targeting multiple pathways (appetite suppression and calorie absorption/reward), but carry higher risks of adverse effects and require strict monitoring.
Combination drugs like Phentermine/Topiramate can achieve nearly 11% weight loss, significantly better than placebo. They work by suppressing appetite and altering brain signaling. However, they have more side effects (dry mouth, taste disturbance, insomnia) and require careful monitoring for cognitive and cardiovascular effects. They are reserved for patients who need more than single-agent therapy.
Supports 2023 - MixedGood
Protein supplementation during endurance training significantly improves time to exhaustion (TTE) with a moderate effect size, despite having no significant effect on maximal oxygen uptake (VO2max) or body composition in the general population.
If you are doing endurance training, adding protein supplements will likely help you exercise for a longer time before exhaustion. However, do not expect this to significantly change your body weight, body fat, or maximum oxygen capacity (VO2max) unless you are currently untrained. Focus on the performance duration benefit rather than body composition changes.
Qualifies 2025New - MixedGood
Untrained individuals may experience greater improvements in maximal oxygen uptake (VO2max) from protein supplementation during endurance training compared to trained individuals.
If you are new to endurance training, adding protein supplements might help slightly improve your maximum oxygen uptake (VO2max). This benefit is likely not present if you are already a trained endurance athlete.
Qualifies 2025New - MixedGood
For recreationally resistance-trained men, performing a split-body resistance training routine with 2 sessions per week per muscle group yields equivalent maximal strength and muscle hypertrophy gains compared to 3 sessions per week, provided total weekly volume is equated.
If you are an experienced lifter, you don't need to train every muscle 3 times a week to maximize gains. You can split your routine over 2 days per muscle group (e.g., 9 sets per muscle per session, twice a week) and get the same strength and muscle growth as training 3 times a week (6 sets per session), as long as you hit the same total weekly volume and train hard.
Refutes 2022 - MixedGood
Higher genetically predicted relative carbohydrate and protein intake is causally associated with a reduced risk of atrial fibrillation.
Focus on increasing your intake of carbohydrates and proteins, but prioritize quality. Choose whole grains, fruits, and vegetables for carbs, and high-quality protein sources. This dietary pattern is associated with a lower risk of atrial fibrillation. Avoid excessive intake of low-quality proteins and ultra-processed foods, as these may increase cardiovascular risk.
Supports 2024 - MixedGood
Lengthened partial repetitions (LPs) elicit similar muscle hypertrophy and strength-endurance adaptations as full range of motion (fROM) resistance training in resistance-trained individuals.
If you are resistance-trained and want to maximize muscle growth or strength, you do not need to force full range of motion if it causes pain or technical breakdown. You can use lengthened partial reps (focusing on the stretched position at the bottom of the movement) to get the same benefits as full reps. Just ensure you are training to failure and pausing in the stretched position. This gives you flexibility to train around injuries or mobility limitations without sacrificing gains.
Supports 2024 - MixedGood
Dumbbell and cable lateral raises produce equivalent lateral deltoid hypertrophy when shoulder abduction/adduction range of motion is standardized and matched between conditions.
You can use either dumbbells or cables for lateral raises to build your side delts. The key is to match the range of motion (lifting your arm to about 90 degrees) and train to failure for 5 sets, twice a week. Don't worry about which machine is 'better' mechanically; just pick the one you prefer and stick with it.
Refutes 2025New - MixedGood
High-intensity interval training (HIIT) engages a unique subset of skeletal muscle signaling pathways and substrates compared to work- and duration-matched moderate-intensity continuous training (MICT), specifically involving kinases like PKC alpha/beta and substrates like MTFP1, which are associated with plasma lactate levels.
To trigger unique muscle adaptations associated with high-intensity training, you don't need to exercise for hours. A short session of 5 minutes of high-intensity intervals (e.g., 1-minute sprints followed by 1-minute recovery, repeated 5 times) is sufficient to activate specific signaling pathways (like PKC and MTFP1) that are not significantly engaged by moderate, continuous exercise of the same total duration and workload. This suggests HIIT is a highly time-efficient strategy for stimulating metabolic and mitochondrial adaptations.
Supports 2024 - MixedGood
Front-of-pack labeling (FOPL) and sugar-sweetened beverage (SSB) taxes are cost-effective population-level primary prevention strategies that reduce consumption, though their effectiveness varies by socioeconomic status and literacy.
Support policies like sugar taxes and clear food labeling. These are proven to reduce sugary drink consumption and encourage companies to make healthier products. While they may not solve obesity alone, they are a cost-effective way to improve population health.
Supports 2025New - MixedGood
Bariatric surgery provides superior, durable weight loss and metabolic improvement compared to non-surgical interventions, including pharmacotherapy.
If you have severe obesity (BMI ≥40, or ≥35 with health issues) and lifestyle changes haven't worked, bariatric surgery is the most effective long-term solution for weight loss and metabolic health. While it has higher upfront costs and risks, it is more cost-effective over time than lifelong medication. Consult a specialist to see if you qualify.
Supports 2025New - MixedGood
Metformin, alpha-lipoic acid (ALA), and GLP-1 receptor agonists are effective, complementary pharmacological interventions for managing metabolic syndrome, with metformin serving as the universal first-line treatment due to its safety, low cost, and wide availability.
For patients with Metabolic Syndrome, especially in crisis or resource-limited settings, start with metformin as the primary treatment due to its proven safety, low cost, and wide availability. Add alpha-lipoic acid (ALA) to target oxidative stress and insulin sensitivity, and consider GLP-1 agonists if cardiovascular risk is high and resources allow. Simplify regimens and use telemedicine to support adherence, as stress and disruption are major barriers to care.
Supports 2025New - MixedGood
The MicroSimulation Core Obesity Model (MS-COM) accurately predicts cardiovascular and mortality outcomes in adults with overweight or obesity, including those with normoglycemia, prediabetes, or type 2 diabetes, supporting its use for evaluating obesity management interventions.
For policymakers and health technology assessment bodies, the MS-COM model provides a reliable tool to evaluate the cost-effectiveness of obesity interventions (like semaglutide 2.4 mg) by accurately predicting long-term cardiovascular and mortality risks in overweight and obese adults, including those with diabetes.
Supports 2025New